Publication | Open Access

Cost-Effectiveness of Tumor Genomic Profiling to Guide First-Line Targeted Therapy Selection in Patients With Metastatic Lung Adenocarcinoma

OncologyTumor HeterogeneityMedicineMetastatic Lung AdenocarcinomaPathologyTumor Genomic ProfilingBronchial NeoplasmCancer GenomicsMolecular DiagnosticsRadiation OncologyLung CancerHealth Sciences